T0	Participants 83 131	children receiving combined cancer chemotherapy.
T1	Participants 281 331	adults and children receiving cancer chemotherapy.
T2	Participants 466 541	children receiving highly emetogenic chemotherapy for various malignancies.
T3	Participants 544 606	total of 51 children (mean age: 7.7 +/- 4.8 year) were studied
T4	Participants 2247 2297	children receiving highly emetogenic chemotherapy.